Novartis at $165: What a Fresh 52-Week High Means Now
As seen on the 24/7 Wall St. homepage on November 4, 2026.
Novartis just took out its February peak, closing at $165, 0.85% above the prior 52-week high. The $311.6 billion drugmaker has now fully recovered the May gap lower and is back in price discovery.
Continue ReadingShow less
Novartis closed at $165 on November 4, clearing the prior 52-week high set in February and entering price discovery territory with no overhead resistance from recent sellers.
The break follows a full recovery from a sharp May gap lower, which means the stock has worked through that trapped supply entirely and the path of least resistance points higher.
Sponsored
Every pullback since the climb from the low $120s has found buyers, strengthening the case that demand has been consistent rather than speculative.
With no technical ceiling from prior price history, the stock's next moves hinge on fundamentals and sentiment, making near-term news flow especially important to track.